Nicolas Vachon becomes head of Christie Innomed

MONTREAL – Christie Innomed is proud to announce the appointment of Nicolas Vachon (pictured) as the new president and CEO, marking the start of an exciting new chapter for the company. With a forward-looking vision and a commitment to innovation, Nicolas will guide the company as it navigates today’s healthcare challenges.

In a posting on LinkedIn, Vachon said: “It is with immense pride and excitement that I am about to start a new chapter. I will soon have the honor of holding the position of chairman and CEO of Christie Innomed, a family business founded in 1954 by my grandfather.

“Since its beginnings, Christie Innomed has distinguished itself in the field of medical imaging equipment and health information technology, with a clear mission: to help improve the quality of care.”

He added, “With more than 200 talented and dedicated employees, trusted clients in Canada and the United States, and leading partners around the world, Christie Innomed is uniquely positioned in the ecosystem. Now more than ever, our role is crucial: to promote access to the right diagnosis, at the right time. Faced with this challenge, I am determined to mobilize our talents, our partners and our solutions to continue to make a real difference.

In an online announcement, the company said: “As we embark on this journey, we remain focused on what truly matters: the well-being of our employees, partners, and clients. Together, we will continue to deliver solutions that drive better outcomes, foster collaboration, and create meaningful impact in the healthcare industry in Canada and the United States.”

It continued, “We are ready more than ever to embrace the future, tackle challenges head-on, and shape the next era of healthcare excellence.”